PLUS1
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -1.00 | -0.06% | 1,728.40 | 1,734.20 | 1,715.20 | 1,725.80 | 1,729.40 | 11:35:15 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1,726.60 | 1,727.20 | 0.60 | 0.03% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,603 | 6,261,557 | 1,726.84p | 108,127,071p | - | 1,429.80 - 1,796.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:45:01 | O | 1,123 | 1,728.227p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| 85.74Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | -p | 0.00% | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 12/05/2019 | 07:20 | Alliance News |  Glaxo's ViiV Healthcare Submits Application For Fostemsavir.. |
| 12/05/2019 | 07:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC ViiV submits NDA to FDA for fostemsavir |
| 12/04/2019 | 12:34 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Emma Walmsley - External Appointment |
| 12/03/2019 | 21:09 | Dow Jones News | Corporate Tax Chiefs Voice Concerns About Global Minimum Tax.. |
| 12/02/2019 | 12:52 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 12/02/2019 | 11:54 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Total Voting Rights |
| 11/26/2019 | 10:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Block listing Interim Review |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 10/29/2019 | 09:13 | - | Sci-B-Vac data is in December. That''s the drug |
| 10/25/2019 | 07:29 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline |
| 10/24/2019 | 14:25 | - | $VBIV VBI Vaccines will collaborate with GlaxoSmithKline ( |
| 10/23/2019 | 12:37 | - | $GSK and $VBIV VBI Vaccines teams up with |
| 10/23/2019 | 11:10 | - | Watch this one go up with Tesaro approval. |
| 10/06/2019 | 11:41 | - | Certainly a great LONG term hold. ;) |
| 10/06/2019 | 11:16 | - | YIKES haha nice up tick with a great divvy. |
| 10/06/2019 | 03:40 | - | $41.99 now. :) |
| 12/19/2018 | 04:42 | - | Yep 39 now with 5% divvy I don''t |
| 12/19/2018 | 04:18 | - | GSK, PFE form consumer-health JV: #msg-145552190. |
Historical GSK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,751.80 | 1,765.40 | 1,690.00 | 1,715.90 | 6,666,793 | -23.40 | -1.34% |
| 1 Month | 1,731.60 | 1,765.60 | 1,677.80 | 1,720.76 | 6,772,779 | -3.20 | -0.18% |
| 3 Months | 1,625.00 | 1,796.40 | 1,612.40 | 1,702.29 | 8,321,246 | 103.40 | 6.36% |
| 6 Months | 1,564.00 | 1,796.40 | 1,561.20 | 1,675.25 | 8,246,057 | 164.40 | 10.51% |
| 1 Year | 1,446.00 | 1,796.40 | 1,429.80 | 1,601.11 | 8,467,558 | 282.40 | 19.53% |
| 3 Years | 1,466.00 | 1,796.40 | 1,236.40 | 1,531.89 | 8,942,757 | 262.40 | 17.9% |
| 5 Years | 1,444.50 | 1,796.40 | 1,227.50 | 1,504.63 | 9,010,510 | 283.90 | 19.65% |
